Two Sigma Advisers’s Generation Bio GBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-11,930
| Closed | -$67.8K | – | 841 |
|
|
2025
Q4 | $67.8K | Buy |
+11,930
| New | +$67.4K | ﹤0.01% | 2263 |
|
|
2025
Q3 | – | Sell |
-19,140
| Closed | -$61.3K | – | 2449 |
|
|
2025
Q2 | $61.3K | Sell |
19,140
-260
| -1% | -$1K | ﹤0.01% | 2244 |
|
|
2025
Q1 | $78.6K | Sell |
19,400
-40
| -0.2% | -$281 | ﹤0.01% | 2271 |
|
|
2024
Q4 | $206K | Sell |
19,440
-2,270
| -10% | -$40.5K | ﹤0.01% | 2117 |
|
|
2024
Q3 | $536K | Sell |
21,710
-5,490
| -20% | -$145K | ﹤0.01% | 1671 |
|
|
2024
Q2 | $767K | Sell |
27,200
-6,160
| -18% | -$200K | ﹤0.01% | 1692 |
|
|
2024
Q1 | $1.36M | Buy |
33,360
+12,120
| +57% | +$285K | ﹤0.01% | 1428 |
|
|
2023
Q4 | $350K | Buy |
21,240
+19,470
| +1,100% | +$339K | ﹤0.01% | 2054 |
|
|
2023
Q3 | $67.1K | Sell |
1,770
-980
| -36% | -$46.4K | ﹤0.01% | 2252 |
|
|
2023
Q2 | $151K | Buy |
2,750
+180
| +7% | +$8.26K | ﹤0.01% | 2143 |
|
|
2023
Q1 | $111K | Buy |
2,570
+90
| +4% | +$4.35K | ﹤0.01% | 2371 |
|
|
2022
Q4 | $97.5K | Sell |
2,480
-1,240
| -33% | -$65.1K | ﹤0.01% | 2303 |
|
|
2022
Q3 | $198K | Buy |
3,720
+1,640
| +79% | +$103K | ﹤0.01% | 2204 |
|
|
2022
Q2 | $136K | Sell |
2,080
-4,820
| -70% | -$315K | ﹤0.01% | 2354 |
|
|
2022
Q1 | $506K | Sell |
6,900
-890
| -11% | -$51.6K | ﹤0.01% | 1981 |
|
|
2021
Q4 | $552K | Buy |
+7,790
| New | +$1.36M | ﹤0.01% | 1868 |
|
Other funds holding GBIO
Two Sigma Advisers's GBIO Position: Q1 2026 in Review
Two Sigma Advisers sold out of Generation Bio (GBIO) in Q1 2026, closing a stake of 11,930 shares — an estimated $67.8K sold.
Two Sigma Advisers first reported a position in GBIO in Q4 2021 and held it in 16 quarters. The position peaked at $1.36M in Q1 2024. 2 funds tracked by Wall St. Rank hold GBIO as of Q1 2026.
- Two Sigma Advisers reported no remaining Generation Bio position as of Q1 2026 after selling out during the quarter.
- Two Sigma Advisers sold 11,930 Generation Bio shares in Q1 2026, an estimated $67.8K.
- Two Sigma Advisers first reported a position in Generation Bio in Q4 2021 and held it in 16 quarters.
- Two Sigma Advisers's Generation Bio position peaked at $1.36M in Q1 2024.
- 2 funds tracked by Wall St. Rank held Generation Bio as of Q1 2026.
Based on Two Sigma Advisers's 13F filing for Q1 2026.